Work on the coronavirus vaccine trial by Oxford-AstraZeneca was put on hold recently when one of the participants in the trial had a serious adverse reaction to the trial vaccine in testing. Steve and Ben examine this story through the lens of typical vaccine developments and how this is nothing unusual. They also discuss other science topics this week including the upcoming September equinox, Australia signing a deal with Germany for future hydrogen exports, and how Australian barley has potentially nine times more flavour than US barley.

Listen to the audio version of this episode at this link: MP3 Audio (RSS)